Kane Biotech Stock Analysis
| KNBIF Stock | USD 0.03 0 12.42% |
Kane Biotech is overvalued with Real Value of 0.0277 and Hype Value of 0.03. The main objective of Kane Biotech pink sheet analysis is to determine its intrinsic value, which is an estimate of what Kane Biotech is worth, separate from its market price. There are two main types of Kane Biotech's stock analysis: fundamental analysis and technical analysis.
The Kane Biotech pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Kane Biotech's ongoing operational relationships across important fundamental and technical indicators.
Kane |
Kane Pink Sheet Analysis Notes
About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Kane Biotech last dividend was issued on the 13th of March 2017. The entity had 1:5 split on the 13th of March 2017. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Kane Biotech is traded on OTC Exchange in the United States.The quote for Kane Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Kane Biotech contact Mark AhrensTownsend at 204 453 1301 or learn more at https://kanebiotech.com.Kane Biotech Investment Alerts
| Kane Biotech generated a negative expected return over the last 90 days | |
| Kane Biotech has high historical volatility and very poor performance | |
| Kane Biotech has some characteristics of a very speculative penny stock | |
| Kane Biotech has accumulated 1.12 M in total debt with debt to equity ratio (D/E) of 7.12, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Kane Biotech has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kane Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Kane Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kane Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kane to invest in growth at high rates of return. When we think about Kane Biotech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.61 M. Net Loss for the year was (4.6 M) with profit before overhead, payroll, taxes, and interest of 568.44 K. | |
| Kane Biotech has accumulated about 2.53 M in cash with (2.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 27.0% of Kane Biotech outstanding shares are owned by corporate insiders |
Kane Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kane Biotech's market, we take the total number of its shares issued and multiply it by Kane Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Kane Profitablity
The company has Profit Margin (PM) of (1.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.72.Technical Drivers
As of the 22nd of July, Kane Biotech secures the Standard Deviation of 5.32, mean deviation of 2.91, and Risk Adjusted Performance of (0.20). Kane Biotech technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kane Biotech information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Kane Biotech is priced some-what accurately, providing market reflects its recent price of 0.0289 per share. As Kane Biotech appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.Kane Biotech Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Kane Biotech for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Kane Biotech short-term fluctuations and highlight longer-term trends or cycles.
Kane Biotech Predictive Daily Indicators
Kane Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kane Biotech pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 0.0289 | |||
| Day Typical Price | 0.0289 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) |
Kane Biotech Forecast Models
Kane Biotech's time-series forecasting models are one of many Kane Biotech's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kane Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Kane Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Kane Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kane shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Kane Biotech. By using and applying Kane Pink Sheet analysis, traders can create a robust methodology for identifying Kane entry and exit points for their positions.
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Kane Biotech is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Kane Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Complementary Tools for Kane Pink Sheet analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |